Vaccination

EU authorizes sale of vaccine against RSV in infants

The EU on Friday authorized the sale of a vaccine to protect infants from respiratory syncytial virus (RSV), a disease that in worst cases can lead to pneumonia and bronchiolitis.

Gerontology & Geriatrics

Many older adults want RSV vaccine, poll shows

The first Americans over age 60 just started rolling up their sleeves to get vaccinated against respiratory syncytial virus, or RSV, now that brand-new vaccines have started to arrive at pharmacies and clinics.

Obstetrics & gynaecology

Most infants with RSV-related critical illness born at term

Most infants requiring intensive care for respiratory syncytial virus are born at term, and do not have underlying medical conditions, according to a study published online Aug. 15 in JAMA Network Open.

page 7 from 26